Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease

被引：4
|
作者：
Wong, Peter K. [1 ,2 ]
Borromeo, Gelsomina L. [3 ]
Wark, John D. [4 ,5 ]
机构：
[1] Midnorth Coast Arthrit Clin, Coffs Harbour, NSW 2450, Australia
[2] Univ New S Wales, Rural Clin Sch, Fac Med, Kensington, NSW 2033, Australia
[3] Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic, Australia
[4] Univ Melbourne, Dept Med, Melbourne, Vic 3052, Australia
[5] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
RHEUMATOLOGY INTERNATIONAL | 2013年 / 33卷 / 09期
关键词：
Bisphosphonate; Osteonecrosis; Jaw; Non-malignant; Bone; OF-THE-LITERATURE; ZOLEDRONIC-ACID; RISK-FACTORS; MULTIPLE-MYELOMA; AMERICAN ASSOCIATION; ORAL BISPHOSPHONATES; POSTMENOPAUSAL WOMEN; PREVENTIVE MEASURES; AVASCULAR NECROSIS; CLINICAL-FEATURES;
D O I：
10.1007/s00296-013-2771-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Bisphosphonates such as alendronate, risedronate and zoledronate have revolutionised the treatment for osteoporosis and Paget's disease. These drugs reduce fracture risk and probably mortality in patients with osteoporosis. However, they have a long in vivo half-life following cessation and may be associated with delayed dental healing and even the devastating complication of osteonecrosis of the jaw (ONJ). Extensive media attention highlighting this issue has caused much concern among patients and healthcare professionals. This paper seeks to provide treating clinicians with a balanced multi-disciplinary review of the available evidence pertaining to this issue and practical advice regarding prevention and management of ONJ.
引用
收藏
页码：2189 / 2198
页数：10
相关论文
共 50 条
  • [1] Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease
    Peter K. Wong
    Gelsomina L. Borromeo
    John D. Wark
    Rheumatology International, 2013, 33 : 2189 - 2198
  • [2] Bisphosphonate-Related Osteonecrosis of the Jaw
    Chien, Hsin-, I
    Chen, Lee-Wei
    Liu, Wen-Chung
    Lin, Cheng-Ta
    Ho, Yen-Yi
    Tsai, Wei-Hsuan
    Yang, Kuo-Chung
    ANNALS OF PLASTIC SURGERY, 2021, 86 (2S) : S78 - S83
  • [3] Bisphosphonate-related osteonecrosis of the jaw
    Otto, S.
    Pautke, C.
    Schieker, M.
    OSTEOLOGIE, 2012, 21 (04) : 291 - 295
  • [4] Bisphosphonate-related osteonecrosis of the jaw
    Young, Pablo
    Finn, Barbara C.
    Adan, Roque S.
    Bruetman, Julio E.
    Lasa, Juan S.
    REVISTA MEDICA DE CHILE, 2010, 138 (10) : 1332 - 1334
  • [5] Bisphosphonate-related osteonecrosis of the jaw
    Brozoski, Mariana Aparecida
    Traina, Andreia Aparecida
    Zindel Deboni, Maria Cristina
    Marques, Marcia Martins
    Naclerio-Homem, Maria da Graca
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2012, 52 (02) : 260 - 270
  • [6] BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW
    Yarom, Noam
    Goss, Alastair
    Lazarovici, Towy Sorel
    Elad, Sharon
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2016, 147 (10): : 776 - 777
  • [7] Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis
    Bhatt, Geetika
    Bhatt, Aashish
    Dragun, Anthony E.
    Li, Xiao-Feng
    Civelek, A. Cahid
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [8] Bisphosphonate-related osteonecrosis of the jaw: specificities
    Paulo, Siri
    Abrantes, Ana Margarida
    Laranjo, Mafalda
    Carvalho, Lina
    Serra, Armenio
    Botelho, Maria Filomena
    Ferreira, Manuel Marques
    ONCOLOGY REVIEWS, 2014, 8 (02) : 44 - 49
  • [9] Bisphosphonate-related osteonecrosis of the jaw: an overview
    Ruggiero, Salvatore L.
    BISPHOSPHONATES AND OSTEONECROSIS OF THE JAW, 2011, 1218 : 38 - 46
  • [10] Management of Bisphosphonate-Related Osteonecrosis of the Jaw
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2009, 10 (05): : 581 - 582
12345